1News 1News: your global news briefing, coming soon on iOS & Android
Coming Soon
Back to Business
Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta - Slideshow
Business September 28, 2026 at 2:17 PM

Mirum Pharmaceuticals, Inc. (MIRM) Discusses Topline Results from Phase III AZURE-1 Study of Brelovitug in Chronic Hepatitis Delta - Slideshow

Seeking Alpha
Read the full story at Seeking Alpha
More Stories
FirstService Residential to manage 4,500-home Orlando community
Business
FirstService Residential to manage 4,500-home Orlando community
🇺🇸 Investing.com 36m ago
Earnings call transcript: Addex Therapeutics falls on H1 2026 update and funding focus
Business
Earnings call transcript: Addex Therapeutics falls on H1 2026 update and funding focus
🇺🇸 Investing.com 36m ago
GRAIL: AdCom's Vote Of Confidence Is Significant
Business
GRAIL: AdCom's Vote Of Confidence Is Significant
🇺🇸 Seeking Alpha 37m ago
1News
Your world briefing, in your pocket

Curated news from 12 countries and 10 languages. Coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play